Home »
COVID-19 Resource Archive
Disclaimer: These resources are from events and publications prior to December 2022. Some information may no longer be accurate. While these materials may be outdated, they represent a valuable historical reference.
Introduction
On this page, we share previously released internal and external updates with our members and the broader pharmaceutical medicine community. These resources were relevant at the time of publication but may now be outdated.
We have collaborated with experts to produce a series of key blog articles, which can be read below. Although these articles remain scientifically rigorous and referenced, please note that they reflect the state of knowledge at the time of their release and may not include the latest developments.
Additionally, we have been actively involved in influencing policy, both independently and in collaboration with partner organizations, to ensure best practices were adhered to in clinical settings and in the ongoing search for treatments at that time.
Page Contents
- How FPM Contributed to Efforts Against the COVID-19 Pandemic
(This section reflects our activities during the pandemic response period.) - FPM Expert Blog Articles on the Development of Vaccines and Therapeutics for COVID-19
(These blog articles were written during the early phases of the COVID-19 vaccine and therapeutic development efforts and may contain historical data.) - Archived Information About COVID-19 Vaccines and Therapeutics
(Information provided here was accurate at the time of release but may now be out of date. Please refer to current health guidelines for the latest updates.) - Use of COVID-19 Vaccines in the UK
(This section describes the use and distribution of COVID-19 vaccines in the UK during the pandemic.) - Archived Useful Links
(The links in this section were relevant at the time of publication, but some may no longer be active or updated.)
Managing Respiratory Diseases: e-Learning Series
Building on insights from our COVID-19 workshop report and recommendations, this free e-learning series on managing respiratory diseases addresses key conditions like COVID-19, influenza, and RSV. It provides healthcare professionals with in-depth knowledge on clinical presentations, treatments, and practical case studies. This series emerged from our extensive research into respiratory disease management, as highlighted in our COVID-19 workshop report.
For more details, visit the Managing Respiratory Diseases page.
How did FPM contribute to the efforts against the COVID-19 pandemic?
FPM DEMENDE COVID-19 Workshop Report May 2022
Read the FPM DEMENDE COVID-19 Workshop Report and Recommendations, May 2022
We issued up-to-date guidance on how our members could volunteer to vaccinate
Our guidance includes first-hand experience on how pharmaceutical physicians have made themselves available to the NHS workforce.
We hosted an eight-webinar series looking at preparedness-planning for public health emergencies
These webinars were free to attend and are available to re-watch on demand.
We scaled-up our public engagement via media appearances
Penny Ward appeared across numerous outlets including this feature on the BBC News website.
Additional media coverage was secured
Former chair of the PCG, Dr Gillies O'Bryan-Tear was prominent across many news outlets. FPM has received unprecedented media requests and our spokespersons have made contributions to the public discourse in UK and overseas media outlets.
We issued re-active and pro-active policy statements on emerging developments
FPM put out a statement welcoming the increase in funding and expansion of the AGILE COVID-19 clinical trials platform.
We tapped into our members' experiences to produce a Clinical Trials Resilience Report
Aware that COVID-19 may have affected ongoing trials in other therapy areas, FPM surveyed its membership at the end of 2020 to gather their voices on these secondary effects of the pandemic.
FPM expert blog articles on the development of vaccines and therapeutics for COVID
Since the start of the COVID-19 pandemic FPM members and other guest authors have produced academically rigorous, internally-reviewed blog articles which have been widely read.
